Michael Forbes, CEO of Adastra, explained in his Original push release: “Harm reduction is a critically crucial and mainstream subject matter, and we have been being on the forefront of drug regulations over the board.”Might market substandard and falsified prescription drugs built or distributed beneath unregulated and likely unsafe solutions,